Global Neurology Academy

MinuteCE®
Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
0.75 credits 6 episodes
- Dani Cabral, MD
- Marwan Sabbagh, MD, FAAN
0.75 credits 6 episodes
NPS Psychosis: Circuits, Treatment, and New Hope
NPS Psychosis: Circuits, Treatment, and New Hope
MinuteCE®
NPS Psychosis: Circuits, Treatment, and New Hope
0.75 program credits
- Dani Cabral, MD
- Mohammed Q. Al-Sabbagh, MD
0.75 program credits
CME/CE In-Person Event
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
Chicago, Illinois
1.50 credits
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
CME/CE Virtual Event
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
07:30 AM - 09:00 AM ET
1.50 credits
NPS Agitation: Evidence and Emerging Mechanisms of Management
NPS Agitation: Evidence and Emerging Mechanisms of Management
MinuteCE®
NPS Agitation: Evidence and Emerging Mechanisms of Management
0.75 program credits
- Dani Cabral, MD
- Mohammed Q. Al-Sabbagh, MD
0.75 program credits
Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
MinuteCE®
Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
0.75 program credits
- Dani Cabral, MD
- Mohammed Q. Al-Sabbagh, MD
0.75 program credits
Unpacking the Genetics of Friedreich’s Ataxia
Unpacking the Genetics of Friedreich’s Ataxia
NeuroFrontiers
Unpacking the Genetics of Friedreich’s Ataxia
- Arnulf Koeppen, MD
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
NeuroFrontiers
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG

Medical News

Medical News
DWI Abnormalities and Stroke in Patients Treated With Lecanemab
04/28/2026
Read more
Medical News
Intra-Arterial Alteplase After Thrombectomy in Basilar Occlusion
04/28/2026
Read more
Medical News
Locus Coeruleus TDP-43 Pathology in Aging Cohort
04/27/2026
Read more
Medical News
Asundexian in Secondary Stroke Prevention After Noncardioembolic Events
04/27/2026
Read more

See more news

CME/CE

CME/CE In-Person & Virtual Event
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
Chicago, Illinois
1.50 credits
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
CME/CE Virtual Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
11:45 AM - 12:45 PM ET
CME/CE In-Person Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
Orlando, Florida
Target Locked in gMG: Why T2T Matters
Target Locked in gMG: Why T2T Matters
MinuteCE®
Target Locked in gMG: Why T2T Matters
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit

Clinical Practice

Is Friedreich’s Ataxia Developmental or Degenerative?
Is Friedreich’s Ataxia Developmental or Degenerative?
NeuroFrontiers
Is Friedreich’s Ataxia Developmental or Degenerative?
- Arnulf Koeppen, MD
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
NeuroFrontiers
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
- Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
NeuroFrontiers
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
FA hiPSCs in Translational Drug Development
FA hiPSCs in Translational Drug Development
NeuroFrontiers
FA hiPSCs in Translational Drug Development

Programs

Tau Therapies and Clinical Translation: Mechanistic Approaches
Tau Therapies and Clinical Translation: Mechanistic Approaches
MinuteCE®
Tau Therapies and Clinical Translation: Mechanistic Approaches
0.75 program credits
- Dani Cabral, MD
- Mohammed Q. Al-Sabbagh, MD
0.75 program credits
Unseen Impact of NPS in AD: Domains and Burden
Unseen Impact of NPS in AD: Domains and Burden
MinuteCE®
Unseen Impact of NPS in AD: Domains and Burden
0.75 program credits
- Dani Cabral, MD
- Mohammed Q. Al-Sabbagh, MD
0.75 program credits
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
NeuroFrontiers
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
- Ryan Quigley
BCMA mRNA CAR-T Shows Durable Benefit in MG
BCMA mRNA CAR-T Shows Durable Benefit in MG
NeuroFrontiers
BCMA mRNA CAR-T Shows Durable Benefit in MG